Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #5132
Reference
Drug alert 26/2013
Name
Drug alert class 2 no.26: action within 48 hours [Glaxo Wellcome UK Limited Trading as GlaxoSmithKline UK: Imigran Injection]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Glaxo Wellcome UK Limited Trading as GlaxoSmithKline UK are recalling five batches of Imigran Injection/Subject to pharmacy, clinic and wholesaler level as a small number of syringes may have needles protruding from the needle shield.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Finance,e-Health and Pharmaceuticals Directorate St Andrew’s House, Regent Road, Edinburgh EH1 3DG
Contact Phone
Created
2013-10-29 00:00:00
Click to go back to homepage